KMT2A and acute myeloid leukemia: Interestingly, Kampen et al. recently proposed a MEK inhibitor escape mechanism in MLL-rearranged AML, which was mediated by VEGFR-2 and PI3K-signaling, and we wondered whether this could play a role in the MEK inhibitor resistance of our wildtype patient cells [5].